Last update 07 Mar 2025
GBiotech SARL

GBiotech SARL

Private Company|
2012|
Switzerland
|
< 10
|
www.geneva-biotech.com

Overview

Tags

Respiratory Diseases
Infectious Diseases
Small molecule drug
Prophylactic vaccine

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Disease DomainCount
Infectious Diseases2
Top 5 Drug TypeCount
Small molecule drug1
Prophylactic vaccine1
Top 5 TargetCount
SARS-CoV-2 S protein1

Related

2
Drugs associated with GBiotech SARL
GB-4
Target-
Mechanism
Immunostimulants
Active Org.
GBiotech SARLGBiotech SARL [+1]
Originator Org.
GBiotech SARLGBiotech SARL
Active Indication
COVID-19
Inactive Indication-
Drug Highest PhasePreclinical
First Approval Ctry. / Loc.-
First Approval Date-
GB-1 (Geneva Biotech)
Target
SARS-CoV-2 S protein
Mechanism
SARS-CoV-2 S protein modulators
Active Org.
GBiotech SARLGBiotech SARL
Originator Org.
GBiotech SARLGBiotech SARL
Active Indication
COVID-19
Inactive Indication-
Drug Highest PhasePreclinical
First Approval Ctry. / Loc.-
First Approval Date-
100 Clinical Results associated with GBiotech SARL
Login to view more data
0 Patents (Medical) associated with GBiotech SARL
Login to view more data
100 Deals associated with GBiotech SARL
Login to view more data
100 Translational Medicine associated with GBiotech SARL
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 09 Mar 2025

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Preclinical
2
1
Other
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
GB-4
COVID-19
More
Preclinical
GB-1 (Geneva Biotech)
 ( SARS-CoV-2 S protein )		COVID-19
More
Preclinical
GB-2
Coronavirus Infections
More
Discontinued
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free